Press release from Companies
Published: 2013-01-10 11:56:24
WntResearch AB (WNT.ST) announces that the patent application for the lead compound of WntResearch, that is Foxy-5, has been granted in China, Australia and Japan.
CEO Nils Brünner comments: "The grant of patents for WntResearch's lead compound Foxy-5 in China, Australia and Japan is very satisfactory and in line with the IP-strategy for Foxy-5. The granting is an important step towards development and commercialization. It is a pre-requisite for partner negotiations and supports that FOXY-5 as an anti-metastatic drug is a new and innovative concept." For further information please contact: Nils Brünner, CEO E-mail: firstname.lastname@example.org Telephone: +45 2614 4708